Viewing Study NCT01774851

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-01-16 @ 11:53 PM
Study NCT ID: NCT01774851
Status: TERMINATED
Last Update Posted: 2017-06-22
First Post: 2013-01-10
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach
Sponsor: Merrimack Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER-2 Gene Amplification View
None Esophagus Cancer View
None Gastroesophageal Junction Cancer View
None Stomach Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER-2 Gene Amplification View
None Esophagus Cancer View
None Gastroesophageal Junction Cancer View
None Stomach Cancer View
None Her2 Positive View
None Her2+ View
None Esophageal Cancer View
None Metastatic View